[1] |
World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard[EB/OL].(2021-03-18)[2021-03-18]. https://covid19.who.int/?gclid=Cj0KCQiA34OBBhCcARIsAG32uvP2GNKkSu8P5yxXT7Q3YnFzNKXq69jFTYfjWIvy4wFTiiuhDQI_2ucaAnM2EALw_wcB.
|
[2] |
Shah M, Woo HG. Omicron: a heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies[J]. Front Immunol, 2022, 12: 830527.
doi: 10.3389/fimmu.2021.830527
|
[3] |
Li M, Lou F, Fan H. SARS-CoV-2 variant Omicron: currently the most complete "escapee" from neutralization by antibodies and vaccines[J]. Signal Transduct Target Ther, 2022, 7(1): 28.
|
[4] |
American Academy of Pediatrics. Children and COVID-19: state-level data report[EB/OL].(2021-02-22)[2021-02-25]. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report.
|
[5] |
世界卫生组织. 儿童和青少年的COVID-19疾病[EB/OL]. (2021-09-29) [2022-03-02]. https://apps.who.int/iris/bitstream/handle/10665/345575/WHO-2019-nCoV-Sci-Brief-Children-andadolescents-2021.1-chi.pdf.
|
[6] |
焦富勇, 马蕾. 加强儿童奥密克戎感染的防治[J]. 中国当代儿科杂志, 2022, 24(4): 345-349.
|
[7] |
傅晓燕, 桂明珠, 谢晓恬. 一家族三代聚集性新型冠状病毒感染诊治的归纳与思考[J]. 临床儿科杂志, 2020, 38(12): 908-911.
|
[8] |
蒋荣猛, 谢正德, 姜毅, 等. 儿童新型冠状病毒感染诊断、治疗和预防专家共识 (第三版)[J]. 中华实用儿科临床杂志, 2021, 36(10): 721-732.
|
[9] |
中国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第九版)[J]. 国际流行病学传染病学杂志, 2022, 49(2): 73-80.
|
[10] |
Jackson WM, Price JC, Eisler L, et al. COVID-19 in pediatric patients: a systematic review[J]. J Neurosurg Anesthesiol, 2022, 34(1): 141-147.
doi: 10.1097/ANA.0000000000000803
|
[11] |
Swann OV, Holden KA, Turtle L, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study[J]. BMJ, 2020, 370: m3249.
|
[12] |
Aleem A, Akbar Samad AB, Slenker AK. Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19)[M]. Treasure Island (FL): StatPearls Publishing, 2022.
|
[13] |
Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)[J]. Front Immunol, 2020, 11: 827.
doi: 10.3389/fimmu.2020.00827
pmid: 32425950
|
[14] |
Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents[J]. N Engl J Med, 2020, 383(4): 334-346.
doi: 10.1056/NEJMoa2021680
|
[15] |
Wu J, Deng W, Li S, et al. Advances in research on ACE2 as a receptor for 2019-nCoV[J]. Cell Mol Life Sci, 202, 78(2): 531-544.
|
[16] |
中华人民共和国国家健康委员会, 国家中医药局. 儿童社区获得性肺炎诊疗规范(2019年版)[J]. 中华临床感染病杂志, 2019, 12(1): 6-13.
|
[17] |
Saravolatz LD, Depcinski S, Sharma M. Molnupiravir and nirmatrelvir-ritonavir: oral COVID antiviral drugs[J]. Clin Infect Dis, 2022, 4: ciac180.
|